Delisting risk
TOMZ · NASDAQ · Industrial - Pollution & Treatment Controls

TOMI Environmental Solutions (TOMZ)

Disinfection and decontamination systems built around SteraMist ionized hydrogen peroxide.

$1.69
At close+0.06 (+3.68%)
Loading prices…

TOMI Environmental Solutions, Inc.TOMZIndustrials

Sells SteraMist iHP equipment, proprietary BIT Solution, and decontamination services for indoor environments, with placements intended to create recurring consumable and support demand. One technology platform supports all product lines and the single reportable segment.

Manufactures, licenses, sells, and services SteraMist decontamination systems, which use a proprietary hydrogen-peroxide solution, a cold-plasma arc, and ionized hydrogen peroxide to treat indoor surfaces, air, rooms, enclosures, and facilities. Its portfolio spans portable units, room and facility systems, enclosure integrations, custom installations, consumables, validation, training, support, and corporate decontamination services.

Serves life sciences, healthcare, food safety, and commercial customers through direct sales, international distributors, service providers, and OEM integrations; the United States remains its largest market, with Canada, the United Kingdom, and Europe as expansion areas. Equipment placements support recurring consumable and service sales, while revenue depends heavily on SteraMist, third-party manufacturing and BIT Solution supply, EPA and local regulatory authorizations, and the pending Carbonium Core transaction's financing, approvals, and Nasdaq conditions.

Company facts

CEOHalden S. Shane
ListedOct 1, 2020
ExchangeNASDAQ
HeadquartersFrederick, MD
CountryUnited States
Employees20
CIK0000314227
ISINUS8900233029

Market cap$12.8M
EPS (ttm)−$0.5165
P/E (ttm)−3.21
ROE-326.6%
P/B8.83
P/S1.84
Dividend yieldDiv yield
Beta0.42vs XLI −0.98

No analyst consensus on record.

Next report
Nov 13, 2026
in 71 days
EPS estimate
−$0.10
Revenue estimate
$3.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

May '25Aug '25Nov '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.15−$0.06−$0.02−$0.02−$0.10−$0.12−$0.05Pending
Estimate−$0.15−$0.03−$0.03−$0.01−$0.02−$0.12−$0.11−$0.10
Surprise0.0%−100.0%+33.3%−100.0%−400.0%0.0%+54.5%

RevenueReportedEstimate

May '25Aug '25Nov '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.1M$1.0M$2.0M$2.0M$1.0M$1.7M$2.2MPending
Estimate$1.5M$1.8M$2.7M$2.7M$2.3M$1.7M$1.8M$3.0M
Surprise−30.4%−42.7%−26.6%−26.6%−56.0%−2.1%+22.0%
Estimate−$0.10
ReportedDue Nov 13, 2026
Estimate$3.0M
ReportedDue Nov 13, 2026
View details

Debt to equity237.60%
Current ratio149.00%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$2.5M$1.1M$1.6M$1.0M$2.0M$1.0M$1.7M$2.2M
Net income$59.0K−$3.3M−$255.6K−$1.2M−$450.3K−$1.8M−$810.6K−$382.3K
Net margin2.3%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$149.1K−$3.1M−$754.5K−$1.1M−$321.4K−$1.6M−$626.3K−$244.1K
YoY growth−1,029.9%−315.6%

Balance sheet, Jun 30, 2026Cash & short-term investments $321.9K · Total debt $3.4M · Total assets $8.4M · Shareholders' equity $1.4M

Revenue
$2.2M
Operating income
−$244.1K
Net income
−$382.3K
View details

No dividends on record.

Institutions16 holders · as of Mar 31, 20264.21%324.2K shares
Insiders6 holders · as of Apr 23, 20262.99%230.2K shares
Otherremainder92.80%7.15M shares

7.70M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

The share count has not been confirmed by a second filing; stakes use it as it stands.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Vanguard Capital Management LLCInstitution
2.94%679,24113Fas of Mar 31, 2026
Boh Soon LimInsiderdirector
0.90%69,508Form 4filed Apr 23, 2026
Kelly AndersonInsiderdirector
0.56%43,458Form 4filed May 13, 2025
Walter C. JohnsenInsiderdirector
0.56%43,458Form 4filed May 13, 2025
Geode Capital Management, LLCInstitution
0.55%128,04813Fas of Mar 31, 2026
See all 25

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Insider tradesForm 4

No open-market trades in the last 12 months.

View details

  • STERIS

    Whole-room and facility H2O2 bio-decontamination for regulated users.

  • Ecolab

    Bioquell H2O2-vapor systems overlap in rooms, cleanrooms, and services.

  • Clorox

    Routine healthcare surface disinfection and electrostatic spraying.

  • Fortive

    ASP STERRAD H2O2 gas-plasma systems share hospital infection-control budgets.

Compare

CompanyPriceChange
TOMI Environmental Solutions$1.69+3.68%$12.8M1.8+117.9%
STERIS$230.58+0.14%$22.45B28.220.13.7+7.8%
Ecolab$283.73+1.33%$78.77B37.632.44.7+9.7%
Clorox$94.61+0.31%$11.40B19.616.21.7−2.0%
Fortive$56.60−0.04%$17.09B33.318.24.0−27.8%
Median30.719.13.8+2.9%